Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2019-09-19

Clinical Trial Update: A Randomized Trial of Rosuvastatin Loading Combined With Early hydrAtion Versus Standard-of-care Medications for the Prevention of CIAKI in Patient With AMI Undergoing Emergency PCI [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial assessing rosuvastatin loading with early hydration versus standard care for prevention of contrast-induced acute kidney injury in AM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Shenyang Northern Hospital | Conditions: Contrast-induced Acute Kidney Injury, ST Elevation Myocardial Infarction | Phase 4 | Status: WITHDRAWN